Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model

Journal of Surgical Research

Volumn 185, Issue 1, 2013, Pages 70-83

  Roy, Rajika ^a   Brodarac, Andreja ^a   Kukucka, Marian ^b   Kurtz, Andreas ^a   Becher, Peter Moritz ^a   Jülke, Kerstin ^a   Choi, Yeong Hoon ^c   Pinzur, Lena ^d   Chajut, Ayelet ^d   Tschöpe, Carsten ^b   Stamm, Christof ^a,b  

^a Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d PLURISTEM THERAPEUTICS INC   (Israel)

Author keywords

Angiogenesis; Cell therapy; Heart; Ischemic heart disease infarction; Placenta cells

Indexed keywords

ANGIOPOIETIN 1; INTERLEUKIN 10; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOREACTOR; CELL THERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPHENOTYPING; ISCHEMIC HEART DISEASE; MICROVASCULATURE; MOUSE; NONHUMAN; PLACENTA; PLACENTA DERIVED HUMAN STROMAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ANGIOGENESIS; CELL THERAPY; HEART; ISCHEMIC HEART DISEASE INFARCTION; PLACENTA CELLS;

ANIMALS; CELLS, CULTURED; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-10; MALE; MICE, INBRED BALB C; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PLACENTA; PREGNANCY; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84886718723     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.05.084     Document Type: Article

References (57)

1. S. Arnous, A. Mozid, J. Martin, and A. Mathur Bone marrow mononuclear cells and acute myocardial infarction Stem Cell Res Ther 3 2012 2
2. Y.H. Choi, K. Neef, and M. Reher The influence of pre-operative risk on the number of circulating endothelial progenitor cells during cardiopulmonary bypass Cytotherapy 12 2010 79
3. K. Neef, Y.H. Choi, and A. Weichel The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness Cytotherapy 14 2012 670
4. C. Stamm, B. Nasseri, T. Drews, and R. Hetzer Cardiac cell therapy: a realistic concept for elderly patients? Exp Gerontol 43 2008 679
5. J.M. Hare, J.H. Traverse, and T.D. Henry A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277
6. W.R. Prather, A. Toren, M. Meiron, R. Ofir, C. Tschope, and E.M. Horwitz The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia Cytotherapy 11 2009 427
7. Y. Ramot, M. Meiron, A. Toren, M. Steiner, and A. Nyska Safety and biodistribution profile of placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery Toxicol Pathol 37 2009 606
8. S. Buitrago, T.E. Martin, J. Tetens-Woodring, A. Belicha-Villanueva, and G.E. Wilding Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice J Am Assoc Lab Anim Sci 47 2008 11
9. C.H. Fang, J. Jin, and J.H. Joe In vivo differentiation of human amniotic epithelial cells into cardiomyocyte-like cells and cell transplantation effect on myocardial infarction in rats: comparison with cord blood and adipose tissue-derived mesenchymal stem cells Cell Transplant 21 2012 1687
10. P.M. Becher, D. Lindner, and K. Miteva Role of heart rate reduction in the prevention of experimental heart failure: comparison between If-channel blockade and beta-receptor blockade Hypertension 59 2012 949
11. S. Sadat, S. Gehmert, and Y.H. Song The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF Biochem Biophys Res Commun 363 2007 674
12. M.J. Reed, T. Koike, E. Sadoun, E.H. Sage, and P. Puolakkainen Inhibition of TIMP1 enhances angiogenesis in vivo and cell migration in vitro Microvasc Res 65 2003 9
13. C.J. Chang, M.L. Yen, and Y.C. Chen Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma Stem Cells 24 2006 2466
14. Y.H. Choi, A. Kurtz, and C. Stamm Mesenchymal stem cells for cardiac cell therapy Hum Gene Ther 22 2011 3
15. B.A. Nasseri, M. Kukucka, and M. Dandel Two-dimensional speckle tracking strain analysis for efficacy assessment of myocardial cell therapy Cell Transplant 18 2009 361
16. B.A. Nasseri, M. Kukucka, and M. Dandel Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy Cell Transplant 16 2007 941
17. C. Yerebakan, A. Kaminski, and B. Westphal Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant J Thorac Cardiovasc Surg 142 2011 1530
18. D.L. Simpson, R. Mishra, S. Sharma, S.K. Goh, S. Deshmukh, and S. Kaushal A strong regenerative ability of cardiac stem cells derived from neonatal hearts Circulation 126 2012 S46
19. C.A. Easley 4th, T. Miki, and C.A. Castro Human amniotic epithelial cells are reprogrammed more efficiently by induced pluripotency than adult fibroblasts Cell Reprogram 14 2012 193
20. C. Heeschen, R. Lehmann, and J. Honold Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease Circulation 109 2004 1615
21. W.A. Noort, R. Willemze, and J.H. Falkenburg Comparison of repopulating ability of hematopoietic progenitor cells isolated from human umbilical cord blood or bone marrow cells in NOD/SCID mice Bone Marrow Transplant 22 Suppl 1 1998 S58
22. S. Sugihara, Y. Yamamoto, and T. Matsuura Age-related BM-MNC dysfunction hampers neovascularization Mech Ageing Dev 128 2007 511
23. P.V. Guillot, C. Gotherstrom, J. Chan, H. Kurata, and N.M. Fisk Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC Stem Cells 25 2007 646
24. T. Miki Amnion-derived stem cells: in quest of clinical applications Stem Cell Res Ther 2 2012 25
25. N. Ma, Y. Ladilov, and A. Kaminski Umbilical cord blood cell transplantation for myocardial regeneration Transplant Proc 38 2006 771
26. N. Ma, Y. Ladilov, and J.M. Moebius Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells Cardiovasc Res 71 2006 158
27. K. Bieback, S. Kern, H. Kluter, and H. Eichler Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood Stem Cells 22 2004 625
28. M. Dominici, K. Le Blanc, and I. Mueller Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315
29. W. Li, N. Ma, and L.L. Ong Bcl-2 engineered MSCs inhibited apoptosis and improved heart function Stem Cells 25 2007 2118
30. X.P. Huang, Z. Sun, and Y. Miyagi Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair Circulation 122 2010 2419
31. K. Le Blanc Mesenchymal stromal cells: tissue repair and immune modulation Cytotherapy 8 2006 559
32. Y.Y. Du, S.H. Zhou, and T. Zhou Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction Cytotherapy 10 2008 469
33. R.A. Banas, C. Trumpower, C. Bentlejewski, V. Marshall, G. Sing, and A. Zeevi Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells Hum Immunol 69 2008 321
34. A. Solomon, M. Wajngarten, and F. Alviano Suppression of inflammatory and fibrotic responses in allergic inflammation by the amniotic membrane stromal matrix Clin Exp Allergy 35 2005 941
35. W. Yuan, C. Zong, and Y. Huang Biological, immunological and regenerative characteristics of placenta-derived mesenchymal stem cell isolated using a time-gradient attachment method Stem Cell Res 9 2012 110
36. P. Nancy, E. Tagliani, C.S. Tay, P. Asp, D.E. Levy, and A. Erlebacher Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface Science 336 2012 1317
37. E. Horwitz Allogeneic cell therapy Regenerative Medicine 6 2011 84
38. C.C. Hughey, V.L. Johnsen, and L. Ma Mesenchymal stem cell transplantation for the infarcted heart: a role in minimizing abnormalities in cardiac-specific energy metabolism Am J Physiol Endocrinol Metab 302 2012 E163
39. D. Furlani, W. Li, and E. Pittermann A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart Cell Transplant 18 2009 319
40. V. Dayan, G. Yannarelli, P. Filomeno, and A. Keating Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model Interact Cardiovasc Thorac Surg 14 2012 516
41. S.A. Chang, E.J. Lee, and H.J. Kang Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation Stem Cells 26 2008 1901
42. S. Makino, K. Fukuda, and S. Miyoshi Cardiomyocytes can be generated from marrow stromal cells in vitro J Clin Invest 103 1999 697
43. A.R. Williams, and J.M. Hare Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease Circ Res 109 2011 923
44. S.H. Liu, J.P. Huang, and R.K. Lee Paracrine factors from human placental multipotent mesenchymal stromal cells protect endothelium from oxidative injury via STAT3 and manganese superoxide dismutase activation Biol Reprod 82 2010 905
45. M. Cohen, W. Sherman, K.P. Rentrop, and R. Gorlin Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects J Am Coll Cardiol 13 1989 297
46. R.W. Eckstein Effect of exercise and coronary artery narrowing on coronary collateral circulation Circ Res 5 1957 230
47. C.L. O'Neill, M.T. O'Doherty, and S.E. Wilson Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells Stem Cell Res Ther 3 2012 31
48. J.M. Tang, J.N. Wang, and L. Zhang VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart Cardiovasc Res 91 2011 402
49. J.T. Butcher, R.A. Norris, S. Hoffman, C.H. Mjaatvedt, and R.R. Markwald Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase Dev Biol 302 2007 256
50. A. Kruzynska-Frejtag, M. Machnicki, R. Rogers, R.R. Markwald, and S.J. Conway Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation Mech Dev 103 2001 183
51. V. Lindner, Q. Wang, B.A. Conley, R.E. Friesel, and C.P. Vary Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration Arterioscler Thromb Vasc Biol 25 2005 77
52. L.W. Stanton, L.J. Garrard, and D. Damm Altered patterns of gene expression in response to myocardial infarction Circ Res 86 2000 939
53. M. Shimazaki, K. Nakamura, and I. Kii Periostin is essential for cardiac healing after acute myocardial infarction J Exp Med 205 2008 295
54. A. Simioniuc, M. Campan, and V. Lionetti Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study Cardiovasc Res 90 2011 546
55. C. Ventura, S. Cantoni, and F. Bianchi Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts J Biol Chem 282 2007 14243
56. A. Barzelay, E. Hochhauser, and M. Entin-Meer Islet-1 gene delivery improves myocardial performance after experimental infarction Atherosclerosis 223 2012 284
57. N. Ma, C. Stamm, and A. Kaminski Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice Cardiovasc Res 66 2005 45